Yong Hao

Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

Jean‐Pierre J. Issa, Gail J. Roboz, David A. Rizzieri et al. · The Lancet Oncology · 2015 · 280 citations · Full text

Hematological Malignancy, Dose-escalation Phase 1, Oncology +9

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms

HJ Sutherland, GM Fyles, Grenfell Adams et al. · Bone Marrow Transplantation · 1997 · 155 citations

Quality Of Life, Patient Reports, Life Assessment +9

Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial

Hagop M. Kantarjian, Gail J. Roboz, Patricia Kropf et al. · The Lancet Oncology · 2017 · 152 citations · Full text

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +11

Treatment of locally recurrent rectal carcinoma—Results and prognostic factors

C. Shun Wong, Bernard Cummings, James D. Brierley et al. · International Journal of Radiation Oncology*Biology*Physics · 1998 · 130 citations

Medicine, Cancer Recurrence, Recurrent Rectal Carcinoma—results +4

Predicting the outcome of postasphyxial hypoxicischemic encephalopathy within 4 hours of birth

Paul G. Ekert, Max Perlman, Maja Steinlin et al. · The Journal of Pediatrics · 1997 · 94 citations

Neonatology, Postasphyxial Hypoxicischemic Encephalopathy, Hypoxia (Medicine) +6